Methotrexate response predicts RA mortality

Rheumatoid arthritis patients are more likely to die earlier if they don’t respond to methotrexate within one year compared with those who do, German researchers say.

Their study of 271 patients shows a poor response to methotrexate after one year of treatment predicted lower mortality during the next 30 years.

However, continued methotrexate treatment over ten years was positively associated with lower